ID: ALA4203055

Max Phase: Preclinical

Molecular Formula: C20H25NO3

Molecular Weight: 327.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1OC)C(C(CO)Cc1ccccc1)NCC2

Standard InChI:  InChI=1S/C20H25NO3/c1-23-18-11-15-8-9-21-20(17(15)12-19(18)24-2)16(13-22)10-14-6-4-3-5-7-14/h3-7,11-12,16,20-22H,8-10,13H2,1-2H3

Standard InChI Key:  AXWCPCPMZNDOGP-UHFFFAOYSA-N

Associated Targets(non-human)

Uterus (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 327.42Molecular Weight (Monoisotopic): 327.1834AlogP: 2.74#Rotatable Bonds: 6
Polar Surface Area: 50.72Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.77CX LogP: 2.74CX LogD: 1.36
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.86Np Likeness Score: 0.92

References

1. Domokos D, Fülöp F, Falkay G, Gáspár R..  (2018)  Effects of newly synthetized isoquinoline derivatives on rat uterine contractility and ROCK II activity.,  28  (3): [PMID:29269216] [10.1016/j.bmcl.2017.12.017]

Source